BACKGROUND: The diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) relies on flow cytometric demonstration of loss of glycosyl-phosphatidyl inositol (GPI)-anchored proteins from red blood cells (RBC) and white blood cells (WBC). High-sensitivity multiparameter assays have been developed to detect loss of GPI-linked structures on PNH neutrophils and monocytes. High-sensitivity assays to detect PNH phenotypes in RBCs have also been developed that rely on the loss of GPI-linked CD59 on CD235a-gated mature RBCs. The latter is used to delineate PNH Type III (total loss of CD59) and PNH Type II RBCs (partial loss of CD59) from normal (Type I) RBCs. However, it is often very difficult to delineate these subsets, especially in patients with large PNH clones who continue to receive RBC transfusions, even while on eculizumab therapy. METHODS: We have added allophycocyanin (APC)-conjugated CD71 to the existing CD235aFITC/CD59PE RBC assay allowing simultaneous delineation and quantification of PNH Type III and Type II immature RBCs (iRBCs). RESULTS: We analyzed 24 medium to large-clone PNH samples (>10% PNH WBC clone size) for PNH Neutrophil, PNH Monocyte, Type III and Type II PNH iRBCs, and where possible, Type III and Type II PNH RBCs. The ability to delineate PNH Type III, Type II, and Type I iRBCs was more objective compared to that in mature RBCs. Additionally, total PNH iRBC clone sizes were very similar to PNH WBC clone sizes. CONCLUSIONS: Addition of CD71 significantly improves the ability to analyze PNH clone sizes in the RBC lineage, regardless of patient hemolytic and/or transfusion status.

Cytoquest Corporation Toronto Ontario Canada

Dahl Chase Diagnostic Services Bangor Maine

EXBIO Praha a s Vestec Czech Republic

HMDS St James University Hospital Leeds UK and Experimental Haematology University of Leeds UK

Institute of Hematology and Blood Transfusion Prague Czech Republic

Laboratory Medicine Program Toronto General Hospital Toronto Ontario Canada

Sprott Centre for Stem Cell Research Ottawa Hospital Research Institute Toronto Ontario Canada

Zobrazit více v PubMed

Battiwalla, M., Hepgur, M., Pan, D., McCarthy, P. L., Ahluwalia, M. S., Camacho, S. H., … Wallace, P. K. (2010). Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations. Cytometry Part B, 78B, 348-356.

Borowitz, M. J., Craig, F., DiGiuseppe, J. A., Illingworth, A., Rosse, W., Sutherland, D. R., … Richards, S. J. (2010). On behalf of the clinical flow Cytometry society. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal Hemoglobinuria and related disorders by flow Cytometry - A consensus guideline. Cytometry Clin Cytom, 72B, 211-230.

Chin-Yee, I., Keeney, M., & Lohmann, R. C. (1991). Flow cytometric reticulocyte analysis using Thiazole Orange; clinical experience and technical limitations. Clinical Laboratory Hematology, 13, 177-188.

Dacie, J. V. (1963). Paroxysmal nocturnal haemoglobinuria. Proceedings of the Royal Society of Medicine, 56, 587-596.

Davis, B. H., Keeney, M., Brown, R., Illingworth, A. J., King, M. J., Kumpel, B., … Sutherland, D. R. C. L. S. I. (2014). H52-A2 red blood cell diagnostic testing using flow Cytometry; approved guideline (2nd ed.). Wayne, PA: Clinical and Laboratory Standards Institute ISBN Number: 1-56238-957-2.

Hall, S. E., & Rosse, W. F. (1996). The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood, 87, 5332-5340.

Hill, A., Rother, R. P., Arnold, L., Kelly, R., Cullen, M. J., Richards, S. J., & Hillmen, P. (2010). Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization. Haematologica, 95, 567-573.

Holguin, M. H., Frederick, L. R., Bernshaw, N. J., Wilcox, L. A., & Parker, C. J. (1989). Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. The Journal of Clinical Investigation, 84, 7-17.

Illingworth, A., Marinov, I., Sutherland, D. R., & Wagner Ballon, O. (2018). DelVecchio. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal Hemoglobinuria (PNH) and related disorders: Part 3; data analysis, reporting and case studies. Cytometry Part B, 94B, 49-66.

Marinov, I., Kohoutova, M., Tkacova, V., Lysak, D., Holubova, M., Stehlikova, O., … Illingworth, A. (2013). Intra- and inter-laboratory variability of paroxysmal nocturnal hemoglobinuria testing by flow cytometry following the 2012 practical guidelines for high-sensitivity paroxysmal nocturnal hemoglobinuria testing. Cytometry Part B., 84B, 229-236.

Miyata, T., Takeda, J., Iida, Y., Yamada, N., Inoue, N., Takahashi, M., … Kinoshita, T. (1993). The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science, 259, 1318-1320.

Morgan, B. P., Boyd, C., & Bubeck, D. (2017). Molecular cell biology of complement membrane attack. Seminars in Cell and Developmental Biology, 72, 124-132.

Nafa, K., Bessler, M., Castro-Malaspina, H., Jhanwar, S., & Luzzatto, L. (1998). The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells, Molecules & Diseases, 24, 370-384.

Naumova, E. V., Plekhanova, O. S., Lugovskaia, S. A., Pochtar, M. E., & Bugrov, I. Y. (2014). The evaluation and comparative characteristic of detection of clone of paroxysmal nocturnal hemoglobinuria on reticulocytes using the technique of flow cytometry. Klinicheskaia Laboratornaia Diagnostika, 59, 25-28.

Nicholson-Weller, A., March, J. P., Rosenfeld, J. P., & Austen, K. F. (1983). Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay acceleration factor. Proceedings of the National Academy of Sciences of the United States of America, 80, 5066-5070.

Oldaker, T., Whitby, L., Saber, M., Holden, J., Wallace, P. K., & Litwin, V. (2018). ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal Hemoglobinuria (PNH) and related disorders: Part 4 - assay validation and quality assurance. Cytometry Part B, 94B, 67-81.

Oni, S. B., Osunkoya, B. O., & Luzzatto, L. (1970). Paroxysmal nocturnal hemoglobinuria: Evidence for monoclonal origin of abnormal red cells. Blood, 36, 145-152.

Parker, C. J. (2002). Historical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease. British Journal of Haematology, 117, 3-22.

Richards, S. J., Rawstron, A. C., & Hillmen, P. (2000). Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry (Comm in Clin Cytom), 42, 223-233.

Rosse, W. F., & Ware, R. E. (1995). The molecular basis of paroxysmal nocturnal Hemoglobinuria. Blood, 86, 3277-3268.

Sadallah, S., Hanno, S., & Schifferli, J. A. (2010). Reticulocytes have a higher resistance to complement lysis than erythrocytes. Acta Haematologica, 123, 153-157.

Sutherland, D. R., Acton, E., Keeney, M., Davis, B. H., & Illingworth, A. (2014). Use of CD157 in FLAER-based assays for high-sensitivity PNH neutrophil and PNH monocyte detection. Cytometry Part B., 86B, 44-55.

Sutherland, D. R., Illingworth, A., Marinov, I., Ortiz, F., Andreasen, J., Payne, D., … Keeney, M. (2018). ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal Hemoglobinuria (PNH) and related disorders: Part 2 - reagent selection and assay optimization for high sensitivity testing. Cytometry Part B, 94B, 23-48.

Sutherland, D. R., Keeney, M., & Illingworth, A. (2012). Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry. Cytometry Part B, 82B, 195-208.

Sutherland, D. R., Kuek, N., Davidson, J., Barth, D., Chang, H., Yeo, E. L., … Keeney, M. (2007). Diagnosing PNH with FLAER and multiparameter flow Cytometry. Cytometry Part B, 72B, 167-177.

Sutherland, D. R., Ortiz, F., Quest, G., Illingworth, A., Benko, M., Nayyar, R., & Marinov, I. (2018). High-sensitivity 5-, 6-, and 7-color PNH WBC assays for both canto II and Navios platforms. Cytometry Part B, 94B, 637-651.

Sutherland, D. R., Richards, S. J., Keeney, M., & Illingworth, A. (2015). High-sensitivity detection of PNH red blood cells, red cell precursors and white blood cells. Current Protocols in Cytometry, 72, 6.37.1-6.37.29.

Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., … Kinoshita, T. (1993). Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell, 73, 703-711.

Thomson-Luque, R., Wang, C., Ntumngia, F. B., Xu, S., Szekeres, K., Conway, A., … Jiang, R. H. Y. (2018). In-depth phenotypic characterization of reticulocytes maturation using mass cytometry. Blood Cells, Molecules and Diseases, 72, 22-33.

van der Schoot, C. E., Huizinga, T. W., van't Veer-Korthof, E. T., Wijmans, R., Pinkster, J., & von dem Borne, A. E. (1990). Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood, 76, 1853-1859.

Ware, R. E., Rosse, W. F., & Hall, S. E. (1995). Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal Hemoglobinuira. Blood, 86, 1586-1589.